Pooling Quebec’s clinical research resources to provide better patient care

How to propel Quebec to global leadership in early clinical research? Dr. Marc Rivière, the new chair of the board of directors of CATALIS Quebec, shares his vision.


CATALIS Québec presents its new board of directors

CATALIS’s management team is pleased to present the seven renowned directors that became its board of directors on March 7th.


A new tool for monitoring clinical research performance in Quebec

CATALIS has announced the implementation of a new automated performance report that will allow public institutions in the health and social service network to more easily access their clinical research performance data.


The Nagano system is now interconnected to all Quebec institutions

CATALIS launches of the new “MULTI” interface, which allows intercommunication among Nagano-connected public institutions in Quebec’s health and social service network for the management and approval of multicentre clinical research projects.


Novartis and Roche join the CATALIS Initiative

Novartis and Roche Join the CATALIS Initiative Industry partnership will help establish Quebec as a global leader in early stage clinical research MONTREAL, February 6, 2019— The CATALIS initiative is proud to announce that pharmaceutical companies Novartis and Roche have joined its partner network. A mere two years after its creation, CATALIS Québec has succeeded in mobilizing Quebec’s key players

Read more


The CATALIS initiative celebrates new partners

The CATALIS initiative celebrates new partners Private and public funding provide essential support and highlight Quebec’s role in the field of early stage clinical trials BOSTON, June 5th, 2018 –  A year following its launch at the BIO conference in 2017, the CATALIS initiative is today proud to announce the arrival of new partners, both financial and medical, which will further

Read more


Merck Canada provides financial and expert support to CATALIS

Progression of Quebec’s world-class Early Clinical Research Ecosystem Merck Canada provides financial and expert support to CATALIS MONTREAL, Quebec (May 9, 2018) – CATALIS is proud to announce that Merck Canada confirms financial and expert support for its early clinical research initiative. This support from Merck Canada contributes to the promotion of this world-class field of research in Quebec. “At

Read more


Successful start for CATALIS

Successful start for CATALIS: initiative gains momentum, strengthening interest in the life sciences ecosystem MONTRÉAL (Quebec), October 25, 2017 —CATALIS presented its five-year plan to their partners’ that will set in motion the initiative announced in the Quebec government’s 2017-2027 Québec Life Sciences Strategy. The mission of CATALIS Quebec Clinical Trials, formerly known as the Early Stage Clinical Trials (ESCT) initiative,

Read more


Danika Laberge named general manager of CATALIS

Danika Laberge named general manager of CATALIS MONTRÉAL (Québec) July 21, 2017 — The CQDM and CATALIS’ executive committee are announcing that Ms. Danika Laberge has been named the organization’s Manager General. “It is with great pleasure that CATALIS’ executive committee has appointed Danika Laberge to the position of Manager General of CATALIS”, stated Diane Gosselin, CQDM’s President and Chief

Read more


A total investment of $6.2 million to foster and promote clinical research in Québec

During the recent BIO International Convention, Gaétan Barrette, Minister of Health and Social Services, announced that the Québec government will be contributing $5.3 million to the early clinical research initiative